Section Arrow
ARMP.NYSE-M
- Armata Pharmaceuticals
Quotes are at least 15-min delayed:2026/04/14 23:10 EDT
Regular Hours
Last
 12.88
+1.19 (+10.18%)
Day High 
13.22 
Prev. Close
11.69 
1-M High
12.52 
Volume 
41.73K 
Bid
10.35
Ask
14
Day Low
11.69 
Open
12.1 
1-M Low
7.4301 
Market Cap 
428.24M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 10.85 
20-SMA 9.78 
50-SMA 9.63 
52-W High 16.34 
52-W Low 1.17 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-4.80/-1.54
Enterprise Value
711.69M
Balance Sheet
Book Value Per Share
-5.97
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HOTHHoth Therapeutics0.6459+0.134+26.18%-- 
ALLOAllogene Therapeutics2.28-0.78-25.49%-- 
VRAXVirax Biolabs Group Limited0.148-0.0184-11.06%-- 
CMNDClearmind Medicine Inc.0.91-0.52-36.36%-- 
REPLReplimune Group1.95+0.25+14.71%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.